Slideshows Images Quizzes

Copyright © 2018 by RxList Inc. RxList does not provide medical advice, diagnosis or treatment. See additional information.

Epanova

Last reviewed on RxList: 8/1/2019
Epanova Side Effects Center

Last reviewed on RxList 8/1/2019

Epanova (omega-3-carboxylic acids) is a lipid-regulating agent used as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (≥ 500 mg/dL) hypertriglyceridemia. Common side effects of Epanova include:

The dosage of Epanova is 2 grams (2 capsules) or 4 grams (4 capsules) once daily. Epanova may interact with drugs affecting coagulation (e.g., anti-platelet agents). Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant before taking Epanova. The effects of this drug on a fetus are unknown. This drug can pass into breast milk and its effect on a nursing infant is unknown. Consult your doctor before breastfeeding.

Our Epanova (omega-3-carboxylic acids) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

QUESTION

What is cholesterol? See Answer
Epanova Professional Information

SIDE EFFECTS

Clinical Trials Experience

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.

Adverse reactions reported by at least 3% of EPANOVA-treated individuals and with a higher incidence than placebo (olive oil), based on pooled data from two clinical trials of 6-and 12-week duration involving subjects with hypertriglyceridemia, are listed in Table 1.

Table 1: Adverse Reactions Occurring at Incidence ≥3% and Greater than Placebo in Placebo-Controlled Trials*

Adverse Reaction Placebo
N=314
EPANOVA
2 g
N=315
EPANOVA
4 g
N=315
Diarrhea 2% 7% 15%
Nausea 1% 4% 6%
Abdominal pain or discomfort 2% 3% 5%
Eructation <1% 3% 3%
* Trials included subjects with hypertriglyceridemia of varying severity.

Additional adverse reactions included vomiting, flatulence and dysgeusia.

In a pool of two longer-term (≥52 weeks) placebo-controlled clinical trials involving 748 patients (376 EPANOVA 4 grams per day; 372 placebo) with chronic gastrointestinal disease, additional common adverse reactions reported more often by EPANOVA-treated patients included abdominal distension, constipation, vomiting, fatigue, nasopharyngitis, arthralgia, and dysgeusia.

Read the entire FDA prescribing information for Epanova (Omega-3-carboxylic Acids Soft-gelatin Capsules)

SLIDESHOW

How to Lower Your Cholesterol & Save Your Heart See Slideshow
Related Resources for Epanova

© Epanova Patient Information is supplied by Cerner Multum, Inc. and Epanova Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors

CONTINUE SCROLLING FOR RELATED SLIDESHOW